RxSight Statistics
Share Statistics
RxSight has 40.64M
shares outstanding. The number of shares has increased by 3.87%
in one year.
| Shares Outstanding | 40.64M |
| Shares Change (YoY) | 3.87% |
| Shares Change (QoQ) | 0.46% |
| Owned by Institutions (%) | 88.77% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 47 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 4.28M, so 10.53% of the outstanding
shares have been sold short.
| Short Interest | 4.28M |
| Short % of Shares Out | 10.53% |
| Short % of Float | 11.06% |
| Short Ratio (days to cover) | 4.02 |
Valuation Ratios
The PE ratio is -48.67 and the forward
PE ratio is -49.13.
RxSight's PEG ratio is
0.98.
| PE Ratio | -48.67 |
| Forward PE | -49.13 |
| PS Ratio | 9.55 |
| Forward PS | 1.8 |
| PB Ratio | 4.75 |
| P/FCF Ratio | -59.69 |
| PEG Ratio | 0.98 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for RxSight.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.36,
with a Debt / Equity ratio of 0.04.
| Current Ratio | 11.36 |
| Quick Ratio | 10.5 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | -0.52 |
| Debt / FCF | -0.55 |
| Interest Coverage | -1755.14 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $280,977.91 |
| Profits Per Employee | $-55,130.52 |
| Employee Count | 498 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 1.86 |
Taxes
| Income Tax | 50K |
| Effective Tax Rate | -0.18% |
Stock Price Statistics
The stock price has increased by -78.65% in the
last 52 weeks. The beta is 1.31, so RxSight's
price volatility has been higher than the market average.
| Beta | 1.31 |
| 52-Week Price Change | -78.65% |
| 50-Day Moving Average | 18.92 |
| 200-Day Moving Average | 37.15 |
| Relative Strength Index (RSI) | 35.85 |
| Average Volume (20 Days) | 982,806 |
Income Statement
In the last 12 months, RxSight had revenue of 139.93M
and earned -27.45M
in profits. Earnings per share was -0.71.
| Revenue | 139.93M |
| Gross Profit | 98.94M |
| Operating Income | -36.86M |
| Net Income | -27.45M |
| EBITDA | -23.76M |
| EBIT | -27.38M |
| Earnings Per Share (EPS) | -0.71 |
Full Income StatementBalance Sheet
The company has 16.71M in cash and 12.3M in
debt, giving a net cash position of 4.41M.
| Cash & Cash Equivalents | 16.71M |
| Total Debt | 12.3M |
| Net Cash | 4.41M |
| Retained Earnings | -622.1M |
| Total Assets | 313.04M |
| Working Capital | 265.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -16.95M
and capital expenditures -5.44M, giving a free cash flow of -22.39M.
| Operating Cash Flow | -16.95M |
| Capital Expenditures | -5.44M |
| Free Cash Flow | -22.39M |
| FCF Per Share | -0.58 |
Full Cash Flow StatementMargins
Gross margin is 70.71%, with operating and profit margins of -26.34% and -19.62%.
| Gross Margin | 70.71% |
| Operating Margin | -26.34% |
| Pretax Margin | -19.59% |
| Profit Margin | -19.62% |
| EBITDA Margin | -16.98% |
| EBIT Margin | -26.34% |
| FCF Margin | -16% |
